D. Lenihan

SGLT2 Inhibitor Use and Risk of Clinical Events in Patients With Cancer Therapy-Related Cardiac Dysfunction.

M. Vaduganathan, M. Scherrer-Crosbie, T. Neilan, 2023, JACC. Heart failure.

Cardiac imaging approaches to evaluate drug-induced myocardial dysfunction.

E. Michelson, P. Sager, J. Mason, 2012, American heart journal.

Risk profiles and incidence of cardiovascular events across different cancer types

D. Lenihan, J. Mitchell, M. Laurie, 2023, ESMO open.

Incidental Coronary Arterial Calcification for Cardiovascular Risk Assessment in Men With Prostate Cancer Undergoing PET/CT Imaging.

Kathleen W. Zhang, B. Baumann, M. Reimers, 2024, Clinical genitourinary cancer.

Differential Expression of Circulating miRNAs and Carfilzomib-Related Cardiovascular Adverse Events in Patients with Multiple Myeloma

T. Langaee, D. Lenihan, Yan Gong, 2024, International journal of molecular sciences.

Becker Digital

S. Giusca, G. Korosoglou, A. Schwarz, 2022 .

Cardio-Oncology and Heart Failure: A Scientific Statement from the Heart Failure Society of America.

Anecita P. Fadol, Sherry-Ann Brown, J. Upshaw, 2024, Journal of cardiac failure.